Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China
Clinical trial NCT03288636 · COMPLETED
Trial details
- NCT number
- NCT03288636
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2017-09-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.